Tiffany Mahmood is an associate in the firm’s Litigation Department and a member of its Intellectual Property group. She joined Goodwin in 2015.

Ms. Mahmood focuses her practice on patent matters, including pharmaceuticals, chemicals and biotechnology. Her experience also includes representing clients in the automotive and computer software fields in the patent context, as well as clients in the fashion industry on trademark and copyright-related matters.

Areas of Practice
Domaines D’Expertise





Professional Experience

Ms. Mahmood has experience representing companies in all stages of patent litigation, from pre-suit investigation through trial. Some of her recent engagements include:

  • Representing Vizbee in a defense of patent infringement lawsuit regarding telecasting technology, filed in the Southern District of New York.
  • Represented Sun Pharmaceuticals, Inc. at trial in a patent infringement case involving a generic drug product to treat rosacea. The case is currently pending in the District of Delaware.
  • Represented Taro Pharmaceuticals, Inc. in a patent infringement case filed in the Eastern District of Texas involving a generic tablet used to treat iron overload caused by blood transfusion. The case settled favorably.
  • Represented AMAG Pharmaceuticals, Inc. in a patent infringement case filed in the District of New Jersey relating to AMAG’s Feraheme® product. The case settled favorably.
  • Represented Actavis Laboratories FL, Inc. in a trial victory over Tris Pharma in federal court in Delaware, paving the way for Actavis to launch a generic version of Quillivant XR® (methylphenidate hydrochloride), a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The court found invalid five patents covering Quillivant®’s formulation and use, which would have protected the drug from generic competition for another 14 years.
  • Represented Teva in a patent infringement action filed by Otsuka relating to Teva’s filing of abbreviated new drug applications for generic versions of Otsuka’s drug Abilify® (aripiprazole). The case against Teva settled favorably before trial.
Professional Experience
Prior to joining Goodwin, Ms. Mahmood was an associate in the New York office on Kenyon & Kenyon.


Ms. Mahmood has been recognized by The Best Lawyers in America Ones to Watch for her work in Litigation - Patent and Patent Law 2022.

Ms. Mahmood was named to The Best Lawyers in America 2021: Ones to Watch.

In The News









J.D., 2014
Fordham University School of Law
LL.M., 2010
Fordham University School of Law
B.Sc., 2005
Imperial College of Science, Technology and Medicine (London)



New York
New Jersey


U.S. District Court for the Southern District of New York
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique